Abstract
This is a review of several new approaches developed at or adopted by the Cooperative Prostate Cancer Tissue Resource (CPCTR) to resolve issues involved in tissue microarray (TMA) construction and use. CPCTR developed the first needle biopsy TMA, allowing researchers to obtain 200 or more consecutive cancer sections from a single biopsy core. Using radiographs of original paraffin blocks to measure tissue thickness we developed a method to produce TMAs with a larger number of usable sections. The modular approach to plan TMA construction is also a novel concept wherein TMAs of different types, such as tumor grade TMAs, metastasis TMA and hormone refractory tumors TMA can be combined to form an ensemble of TMAs with expanded research utility, such as support for tumor progression studies. We also implemented an open access TMA Data Exchange Specification that allows TMA data to be organized in a self-describing XML document annotated with well-defined common data elements. It ensures inter-laboratory reproducibility because it offers information describing the preparation of TMA blocks and slides. There are many important aspects that may be missed by both beginners and experienced investigators in areas of TMA experimental design, human subjects protection, population sample size, selection of tumor areas to sample, strategies for saving tissues, choice of antibodies for immunohistochemistry, and TMA data management.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berman JJ, Edgerton ME, Friedman B (2003) The tissue microarray data specification: a community-based open source tool for sharing tissue microarray data. BMC Med Inform Decis Mak 3:5
Berman JJ, Datta M, Kajdacsy-Balla A, Melamed J, Orenstein J, Dobbin K, Patel A, Dhir R, Becich MJ (2004) The tissue microarray data exchange specification: implementation by the cooperative prostate cancer tissue resource. BMC Med Inform Decis Mak 5:19
Chandran UR, Dhir R, Ma C, Michalopoulos G, Becich M, Gilbertson J (2005) Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer 5:45
Datta MW Datta MW, Kahler A, Macias V, Brodzeller T (2005) A simple inexpensive method for the production of tissue microarrays from needle biopsy specimens: examples with prostate cancer. Appl Immunohistochem Mol Morphol 13:96–103
Davol PA, Bagdasaryan R, Elfenbein GJ, Maizel AL, Frackelton AR Jr (2003) Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. Cancer Res 63:6772–6783
DiVito KA, Charette LA, Rimm DL, Camp RL (2004) Long-term preservation of antigenicity on tissue microarrays. Lab Invest 84:1071–1078
Garewal H, Ramsey L, Fass R, Hart NK, Payne CM, Bernstein H, Bernstein C (2003) Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Dig Dis Sci 48:197–202
Guzman G, Layden TJ, Layden-Almer J, Testa G, Benedetti E, Kajdacsy-Balla A, Cotler SJ (2005) p53, Ki-67 and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Mod Pathol 18:1498–1503
Henson DE (1996) Loss of p53-immunostaining intensity in breast cancer. J Natl Cancer Inst 88:1015–1016
Kong X, Zhao Y, Ksionsk M, Meisheng Z, Walden P, Bosland M, Zhiheng P, Peng L, Melamed J (2006) Radiographic determination of tissue thickness in paraffin blocks: application to the construction of tissue microarrays. Appl Immunohistochem Mol Morphol (in press)
Li R, Ni J, Bourne P, Yeh S, Yao J, di Sant’Agnese AP, Huang J (2005) Cell culture block arrays for immunocytochemical study of protein expression in cultured cells. Appl Immunohistochem Mol Morphol 13:85–90
Liu CL, Montgomery KD, Natkunam Y, West RB, Nielsen TO, Cheang MCU, Turbin DA, Marinelli RJ, van de Rijn M, Higgins JPT (2005) TMA-Combiner, a simple software tool to permit analysis of replicate cores in tissue microarrays. Mod Pathol 18:1641–1648
Matysiak B, Brodzeller T, Buck S, French A, Counts C, Boorsma B, Datta MW, Kajdacsy-Balla A (2003) Simple, inexpensive method for automating tissue microarray production provides enhanced microarray reproducibility. Appl Immunol Molecul Morph 11:269–273
Melamed J, Datta M, Becich MJ, Orenstein JM, Silver S, Fidelia-Lambert M, Kajdacsy-Balla A, Macias V, Patel A, Walden PD, Bosland MC, Berman JJ (2004) The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers. Clin Cancer Res 10:4614–4621
Montgomery K, Zhao S, van de Rijn M, Natkunam Y (2005) A novel method for making tissue microarrays from small numbers of suspension cells. Appl Immunohistochem Mol Morphol 13:80–84
Moskaluk CA, Stoler M (2003) Agarose mold embedding of culture cells from tissue microarrays. Diagn Mol Pathol 11:234–238
Pallares J, Bussaglia E, Martinez-Guitarte JL, Dolcet X, Llobet D, Rue M. Sanchez-Verde L, Palacios J, Prat J, Matias-Guiu X (2005) Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities. Mod Pathol 18:719–727
Rubin MA, Dunn R, Strawderman M, Pienta KJ (2002) Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 26:312–319
Oyama T, Allsbrook WC Jr, Kurokawa K, Matsuda H, Segawa A, Sano T, Suzuki K, Epstein JI (2005) A comparison of interobserver reproducibility of gleason grading of prostatic carcinoma in Japan and the United States. Arch Pathol Lab Med 129:1004–1010
Umemura S, Itoh J, Itoh H, Serizawa A, Saito Y, Suzuki Y, Tokuda Y, Tajima T, Osamura RY (2004) Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures? Appl Immunohistochem Mol Morphol 12:8–13
Wild PJ, Kunz-Schughart LA, Stoehr R, Burger M, Blaszyk H, Simon R, Gasser T, Mihatsch M, Sauter G, Hartmann A (2005) High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer. Int J Oncol 27:385–391
Zha S, Gage WR, Sauvageot J, Saria EA, Putzi MJ, Ewing CM, Faith DA, Nelson WG, De Marzo AM, Isaacs WB (2001) Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Res 61:8617–8623
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Kajdacsy-Balla, A., Geynisman, J.M., Macias, V. et al. Practical aspects of planning, building, and interpreting tissue microarrays: The Cooperative Prostate Cancer Tissue Resource experience. J Mol Hist 38, 113–121 (2007). https://doi.org/10.1007/s10735-006-9054-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-006-9054-5